A Deep‐Red‐Absorbing Osmium(II) Complex as a Photosensitizer for Photodynamic Therapy Inducing Immunogenic Cell Death
T cells and reprogramming of macrophages, leading to effective inhibition of tumor growth. Os2 is, to the best of our knowledge, the first photoactive osmium-based complex inducing ICD.
Authors
- Bruno Saubaméa (ORCID: https://orcid.org/0000-0002-6218-0460)
- E. Izquierdo (ORCID: https://orcid.org/0000-0002-7253-6934)
- João P. M. António (ORCID: https://orcid.org/0000-0002-0144-694X)
- Johanne Séguin (ORCID: https://orcid.org/0000-0001-5689-7046)
- Pierre Mesdom (ORCID: https://orcid.org/0000-0003-1069-2138)
- Ruonan Gao
- Gilles Gasser (ORCID: https://orcid.org/0000-0002-4244-5097)
- Bich‐Thuy Doan (ORCID: https://orcid.org/0000-0002-1961-9175)
- Philippe Arnoux
- Yiyi Zhang (ORCID: https://orcid.org/0000-0002-7572-5685)
- Céline Frochot
- Kevin Cariou (ORCID: https://orcid.org/0000-0002-5854-9632)
- Morgane Moinard
Institutions
- Centre National de la Recherche Scientifique (FR)
- University of Lisbon (PT)
- Chimie ParisTech - PSL (FR)
- Inserm (FR)
- Université Paris Cité (FR)
- Université Paris Sciences et Lettres (FR)
- Unité de Technologies Chimiques et Biologiques pour la Santé (FR)
- Instituto de Química Orgánica General (ES)
- Universitat de Barcelona (ES)
- Université de Lorraine (FR)
Publication Details
- Journal
- Angewandte Chemie International Edition
- Published
- 2026-05-11
- DOI
- https://doi.org/10.1002/anie.8677989
- Citations
- 1
- Primary Topic
- Photodynamic Therapy Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 17.99
Funders
- China Scholarship Council